2023年6月7日,

LEADOPTIK——矽穀的醫學成像公司宣布它已經籌集了500萬美元的超額認購係列種子資金由從SOSV MetaVC與參與合作,索尼的創新基金,TSVC, ENEA,喬·(Dropbox的創始人之一),雷在撥弄(確定)的創始人之一,和其他人。這一輪融資將使LEADOPTIK搬到產品開發的下一階段——包括FDA的批準,在商業化之路。該公司正在開發一種小型成像係統進入了一個新的水平人類肺部深處的實時成像,使癌症的早期診斷。並結合小說納米製造和創新的光學超材料技術,公司的產品將允許外科醫生視圖對象五十次小於什麼是可能的與現有成像係統。利用專有的光學介質metasurfaces, LEADOPTIK縮小光學元素大小類似的人類頭發。,由於其前所未有的體積小,由先進的成像軟件,探測器可以通過旅行即使最窄的航空公司,使實時成像和檢測微小的腫瘤。此外,LEADOPTIK小形式的調查與活檢針,允許其集成期間提供實時指導活檢程序。這種集成提高活檢的準確性至關重要,往往盲目地執行。據世界衛生組織統計,肺癌著稱的負責全世界最高的癌症相關的死亡人數。和早期發現和診斷病人的生存是至關重要的; however, there are currently no effective approaches for diagnosing cancer at its earliest stages. KEY QUOTES: “As a technical CEO, I feel incredibly fortunate to witness how my work on metasurface technology has the potential to enhance people’s health. This funding is a very encouraging step to get us closer to that goal.” — Reza Khorasaninejad, co-founder and CEO of LEADOPTIK “I am thrilled to be part of this exciting journey and grateful for the support of visionary investors who are helping us bring the true benefits of this cutting-edge technology to patients.” — Jiang You, co-founder of LEADOPTIK “We look for exciting investment opportunities like LEADOPTIK, where breakthroughs are being made with novel solutions like optical metamaterials.” — Conrad Burke, managing partner at MetaVC Partners “We believe that such technology innovation has the potential to transform healthcare, particularly in areas such as cancer diagnostics, where there is a large unmet need for more accurate and timely screening and diagnosis. The work that LEADOPTIK is doing in developing novel imaging technologies to address lung cancer detection is a perfect example of that.” — Austin Noronha, Managing Director-US, Sony Ventures Trending on Pulse 2.0